The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
Saved in:
| Title: | The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis. |
|---|---|
| Authors: | Barker BE; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Hanlon MM; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Marzaioli V; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Smith CM; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Cunningham CC; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Fletcher JM; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Veale DJ; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Fearon U; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Canavan M; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2023 Feb 03; Vol. 10, pp. 1029021. Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
